Shore Orthopaedic Group, LLC v. EQUITABLE LIFE ASSUR. SOC.

938 A.2d 962, 397 N.J. Super. 614
CourtNew Jersey Superior Court Appellate Division
DecidedJanuary 24, 2008
StatusPublished
Cited by15 cases

This text of 938 A.2d 962 (Shore Orthopaedic Group, LLC v. EQUITABLE LIFE ASSUR. SOC.) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Shore Orthopaedic Group, LLC v. EQUITABLE LIFE ASSUR. SOC., 938 A.2d 962, 397 N.J. Super. 614 (N.J. Ct. App. 2008).

Opinion

938 A.2d 962 (2008)
397 N.J. Super. 614

SHORE ORTHOPAEDIC GROUP, LLC, Plaintiff-Appellant/Cross-Respondent
v.
The EQUITABLE LIFE ASSURANCE SOCIETY OF the UNITED STATES, Defendant-Respondent/Cross-Appellant, and
EQ Financial Consultants, Inc., Alexander Borsuk, Louis Farkas and the John F. Krahnert Agency, Defendants.

Superior Court of New Jersey, Appellate Division.

Argued September 10, 2007.
Decided January 24, 2008.

*964 Mark E. Duckstein, Newark, argued the cause for appellant/cross-respondent (Sills Cummis Epstein & Gross, attorneys; Mr. Duckstein, of counsel and on the brief).

Kim Kocher, argued the cause for respondent/cross-appellant (White and Williams, attorneys, Philadelphia, PA; Jeanne O. Marino, Hackensack, of counsel; Ms. Marino and Ms. Kocher, on the brief).

Before Judges STERN, A.A. RODRÍGUEZ and C.S. FISHER.

The opinion of the court was delivered by

STERN, P.J.A.D.

Following the entry of final judgment, plaintiff Shore Orthopaedic Group ("Shore") appeals from an order of April 1, 2005, denying its application for counsel fees under Rule 4:42-9(a)(6), or, alternatively, "pursuant to the Frivolous Litigation statute," N.J.S.A. 2A:15-59.1. Judge Robert O'Hagan rejected defendant insurer's disclaimer and effort to rescind its "Business Overhead Expense" disability policy issued to Shore as owner, with respect to Dr. Michael Absatz, as insured, and granted summary judgment on coverage to Shore, for which there is no cross-appeal.[1] The judge also denied Shore's *965 post-judgment motion for counsel fees, concluding this was neither a "first party" action nor a frivolous claim. However, by order of June 30, 2005, the judge awarded Shore $50,000 as a sanction for a discovery violation, from which defendant ("Equitable") cross-appeals.

Plaintiff asserts that Rule 4:42-9(a)(6) applies because this case dealt with a third party claim on "a liability or indemnity policy of insurance," and N.J.S.A. 2A:15-59.1 applies because Equitable "knew or should have known that its counterclaims were meritless," and that it is therefore entitled to counsel fees. On its cross-appeal from that part of the April 1, 2005 and June 30, 2005 orders awarding $50,000 in fees and costs as a sanction, Equitable asserts that Shore had "already [been] compensated for all of the fees and costs incurred as a result of the delay" and the discovery motion for which it had been awarded $3,000 in fees and costs.[2] Equitable also claims that there was no rational basis for the award nor "scruti[ny]" of the fee application which included time for the discovery motion which had already been the subject of an award and conferences by attorneys in the plaintiff's firm who duplicated review of the same material.

We affirm the judgment in all respects.

I.

On November 7, 1994, Shore, an orthopedic group of practitioners, applied for a Disability Overhead Expense policy with defendant insurer for coverage in the event that its associate Dr. Michael Absatz became disabled and was unable to pay his share of the overhead expenses of the group. Plaintiff was the owner of the policy and paid all of the premiums, although Dr. Absatz was the "insured." The policy provided that all benefits would be paid directly to Shore as "the owner."

In November 1994, Shore made an initial premium payment in order to obtain "conditional receipt" coverage pending review of the application and the carrier's determination that Absatz was "a standard insurable risk." The application stated:

If at least a minimum deposit is made, we will insure the Proposed Insured if s/he is a standard insurable risk on the effective date. The insurance provided will:
i) take effect as of the effective date;
ii) be exactly as requested for individual coverage in the application; and
iii) continue until we notify you that the application is accepted, modified or filed, but in no event longer than 60 days from the effective date.

On December 12, 1994, Equitable's underwriting department issued a memorandum to its agent requesting a recheck of Dr. Absatz's blood pressure. It was known he was under treatment for a dental *966 condition called acute necrotizing ulcerative gingivitis and had high blood pressure. The application was deemed "incomplete" until the recheck of Dr. Absatz's blood pressure. On January 23, 1995, Equitable sent a letter to Dr. Absatz stating that the file was deemed "incomplete" and that he would need to contact the sales representative to resolve the issues before a policy could be issued. Shore's original premium check was returned to defendant's agent who then returned it to Equitable with the new blood pressure readings.

On February 14, 1995, Dr. Absatz submitted new blood pressure readings as a result of which it was determined that he was a standard underwriting risk. Equitable asserted that the underwriting department received the new readings on February 27, 1995, and its in-house medical consultant reviewed them on March 7, 1995.

On March 4, 1995, Dr. Absatz had a biopsy performed on the area of his mouth afflicted with the gingivitis. On March 10, 1995, Dr. Absatz was diagnosed with palate cancer, but Equitable was not so advised.

On April 21, 1995, Equitable issued the policy naming Dr. Absatz as insured. The policy was dated April 7, 1995. Upon receipt, Dr. Absatz acknowledged both a "Policy Issue Information Sheet" and "Amendment to Application."

On July 22, 1998, "due to the progression of [a] neurologic deficit cause[d] by [the] radiation" for his "recurrent squamous cell cancer," Dr. Absatz's medical condition rendered him totally disabled to perform orthopedic surgery. As a result, Shore submitted a claim for benefits under the policy.

Equitable denied the claim, informing Shore by letter, dated January 19, 1999, that Dr. Absatz did not disclose the diagnosis of cancer which was made during the application process and before the policy was issued. According to Equitable's claims representative, had it known of the condition, the policy would never have been issued, and it was being "rescind[ed]." Shore and Absatz contested the disclaimer, by letter from counsel dated April 15, 1999, which stated, among other things, that because the Conditional Receipt policy was purchased in November 1994, and Absatz had met the standard underwriting criteria on February 14, 1995, discovery of the oral cancer in March 1995 did not need to be reported. Shore's complaint, seeking the policy benefits, was filed on May 25, 2001. In that context the impact of Equitable's policies and procedure relating to conditional receipt coverage became important.

Starting in August 2001, Shore unsuccessfully requested that Equitable produce its underwriting manual and all other manuals in force at the time that the conditional receipt and policy were issued. After three years of unsuccessfully endeavoring to obtain this discovery, two of Equitable's sales agents testified in depositions that defendant did, in fact, have extensive libraries of manuals which revealed that its responses to plaintiff's requests for production were not accurate.

Shore thereafter continued unsuccessfully in its attempts to obtain production of the underwriting manuals. Finally, on July 16, 2004, plaintiff filed a motion to compel production of the manuals.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bricks Flower Market, LLC v. Brick Flower Market, LLC
New Jersey Superior Court App Division, 2026
Anna K. D'antonio v. the Newark Public Schools, Etc.
New Jersey Superior Court App Division, 2025
Days Inns Worldwide, Inc., Etc. v. Basco Trust
New Jersey Superior Court App Division, 2025
In the Matter of the Estate of Tyrone May, Sr.
New Jersey Superior Court App Division, 2025
Asap Realty, Inc. v. Yosef Birnboim
New Jersey Superior Court App Division, 2024
Greenbriar Community Association, Inc. v. Carla McGruder
New Jersey Superior Court App Division, 2024
Anthony Festa, M.D. v. Vincent McInerney, M.D.
New Jersey Superior Court App Division, 2024
Thomas Demarco v. Sean Robert Stoddard, D.P.M.
84 A.3d 965 (New Jersey Superior Court App Division, 2014)
Stoney v. Maple Shade Tp.
44 A.3d 601 (New Jersey Superior Court App Division, 2012)
Baratta v. Deer Haven, LLC
70 A.3d 768 (New Jersey Superior Court App Division, 2011)
Moper Transp., Inc. v. Norbet Trucking Corp.
943 A.2d 873 (New Jersey Superior Court App Division, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
938 A.2d 962, 397 N.J. Super. 614, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shore-orthopaedic-group-llc-v-equitable-life-assur-soc-njsuperctappdiv-2008.